FCCC LOGO Faculty Publications
Chen PR , Balachandran S
Development of interferon gamma-based immunocytokines targeting renal cancer
Oncoimmunology. 2013 Jul;2(7) :e24964
PMID: WOS:000324588300004    PMCID: PMC 3782162   
Back to previous list
Abstract
Advanced renal cancer is an incurable malignancy in need of novel therapeutic avenues. We have generated interferon (IFN)-based fusion antibodies (immunocytokines) that target CD70, a putative biomarker of renal cancer. These immunocytokines efficiently labeled renal cancer cells, and, when combined with the proteasome inhibitor bortezomib, killed them by activating a RIP1-dependent necrotic pathway.
Notes
Chen, Peirong Balachandran, Siddharth